Mitochondrial dysfunction is associated with various chronic diseases and cancers, including neurodegenerative diseases and ...
This investment follows the company’s successful 2025 closing of its $150M Series G round, led by Revival Healthcare Capital.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback